Related Experiment Video

Updated: Jul 8, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis

X Xing1, S C Wang, W Xia

  • 1The University of Texas M.D. Anderson Cancer Center, Department of Cancer Biology, Section of Molecular Cell Biology, Houston, Texas 77030, USA.

Nature Medicine
|February 2, 2000
PubMed

Insights

Researchers found that the PEA3 protein can suppress HER-2/neu overexpression, a key factor in cancer development. This discovery offers a new strategy for targeting HER-2/neu-driven cancers and designing gene-based therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • HER-2/neu overexpression is a critical driver in various cancers.
  • Targeting HER-2/neu is a significant challenge in cancer therapy.

Purpose of the Study:

  • To identify a method for suppressing HER-2/neu overexpression.
  • To investigate the role of PEA3 in regulating HER-2/neu promoter activity.

Main Methods:

  • Identified PEA3 as a DNA-binding protein targeting the HER-2/neu promoter.
  • Assessed the effect of PEA3 expression on HER-2/neu promoter activity.
  • Evaluated the impact of PEA3 on cancer cell growth and tumor development.

Main Results:

  • PEA3 specifically targets a DNA sequence on the HER-2/neu promoter.
  • PEA3 downregulates HER-2/neu promoter activity.
  • PEA3 expression inhibits cell growth and tumor development in HER-2/neu-overexpressing cancer cells.

Conclusions:

  • PEA3 is a novel repressor of HER-2/neu.
  • PEA3 offers a new therapeutic strategy for HER-2/neu-overexpressing cancers.
  • This study provides a rationale for designing gene-based repressors for diseases driven by pathogenic gene overexpression.

More Related Videos

Three-Dimensional (3D) Tumor Spheroid Invasion Assay12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...